University of Minnesota and Glaxo's Ziagen

[James Love <love@cptech.org>]

This is a store regarding the University of Minnesota and 
Glaxo's Ziagen.  Apparently Glaxo had infringed on a number
of Professor Robert Vince's patents.  I looked at several
of his patents, and several have US government
rights under the Bayh-Dole Act.

 Jamie


<-------------Pioneer Press article---------------->

AIDS Drug Royalties Could Boost Research Funds at University
              of Minnesota 

By Linda Owen and Karen Padley, Saint Paul Pioneer Press, Minn.
Knight Ridder/Tribune Business News Oct. 6--A patent lawsuit
settlement announced Tuesday could bring up to $300 million into
the University of Minnesota's coffers to support research and
development, graduate student fellowships and the transfer of
research discoveries into the marketplace. 


    [snip]

The legal dispute centered on whether the AIDS drug Ziagen,
manufactured and sold by Glaxo Wellcome Inc., is covered by several
patents of pharmacy Prof. Robert Vince. Vince invented and patented
antiviral compounds that led to the drug's development. 

Ziagen, used as part of an AIDS drug "cocktail," has sold well.
Through the first six months of 1999, it generated $55 million in
international sales, including $43.7 million in the United States.
Analysts generally expect sales to rise as resistance to existing
AIDS drugs increases. They have predicted that at its peak, Ziagen
will generate $300 million to $800 million annually. 

   [snip] 

But Marilyn Speedie, dean of the College of Pharmacy, said one
reason for optimism about sales of Ziagen is that it need only be
taken twice a day. That should improve compliance among AIDS
patients who otherwise endure "horrendous" drug regimens, she said.

  [snip]


----- Visit PioneerPlanet, the World Wide Web site of the Saint
Paul Pioneer Press, at http://www.pioneerplanet.com